SK160095A3 - Novel (1-phenyl-1-heterocyclyl)methanol and (1-phenyl-1-heterocyclyl)methylamine derivatives - Google Patents

Novel (1-phenyl-1-heterocyclyl)methanol and (1-phenyl-1-heterocyclyl)methylamine derivatives Download PDF

Info

Publication number
SK160095A3
SK160095A3 SK1600-95A SK160095A SK160095A3 SK 160095 A3 SK160095 A3 SK 160095A3 SK 160095 A SK160095 A SK 160095A SK 160095 A3 SK160095 A3 SK 160095A3
Authority
SK
Slovakia
Prior art keywords
lower alkyl
group
methyl
formula
compound
Prior art date
Application number
SK1600-95A
Other languages
English (en)
Slovak (sk)
Inventor
Bernard R Boar
Alan J Cross
Duncan A Gray
Alfred R Green
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE9302334A external-priority patent/SE9302334D0/xx
Application filed by Astra Ab filed Critical Astra Ab
Publication of SK160095A3 publication Critical patent/SK160095A3/sk

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/32Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/24Radicals substituted by oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
SK1600-95A 1993-07-06 1994-07-05 Novel (1-phenyl-1-heterocyclyl)methanol and (1-phenyl-1-heterocyclyl)methylamine derivatives SK160095A3 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
SE9302334A SE9302334D0 (sv) 1993-07-06 1993-07-06 New compounds
US08/379,469 US5712299A (en) 1993-07-03 1994-07-05 (1-phenyl-1-heterocyclyl)methanol and (1-phenyl-1-heterocyclyl methylamine derivatives
PCT/SE1994/000665 WO1995001968A1 (en) 1993-07-06 1994-07-05 Novel (1-phenyl-1-heterocyclyl)methanol and (1-phenyl-1-heterocyclyl)methylamine derivatives
US45663795A 1995-06-02 1995-06-02

Publications (1)

Publication Number Publication Date
SK160095A3 true SK160095A3 (en) 1997-06-04

Family

ID=27355726

Family Applications (1)

Application Number Title Priority Date Filing Date
SK1600-95A SK160095A3 (en) 1993-07-06 1994-07-05 Novel (1-phenyl-1-heterocyclyl)methanol and (1-phenyl-1-heterocyclyl)methylamine derivatives

Country Status (19)

Country Link
US (1) US5712299A (cs)
EP (1) EP0707574A1 (cs)
JP (1) JPH08512314A (cs)
CN (1) CN1047169C (cs)
AU (1) AU691821B2 (cs)
BR (1) BR9406925A (cs)
CA (1) CA2164960A1 (cs)
CZ (1) CZ4296A3 (cs)
FI (1) FI960078A (cs)
HU (1) HUT74671A (cs)
IL (1) IL110158A (cs)
MX (1) MX9405111A (cs)
NO (1) NO305953B1 (cs)
NZ (1) NZ268691A (cs)
PL (1) PL179015B1 (cs)
SG (1) SG48081A1 (cs)
SK (1) SK160095A3 (cs)
WO (1) WO1995001968A1 (cs)
ZA (1) ZA944647B (cs)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0758323A1 (en) * 1994-05-02 1997-02-19 Zeneca Limited Herbicidal hydroxybenzyl-substituted heteroaryl compounds and derivatives thereof
WO1999054309A1 (en) * 1998-04-23 1999-10-28 Takeda Chemical Industries, Ltd. Naphthalene derivatives, their production and use
SE9904177D0 (sv) * 1999-11-18 1999-11-18 Astra Ab Novel compounds
HUP0400807A2 (hu) 2000-11-27 2004-07-28 Pfizer Products Inc. EP4 receptor szelektív agonisták csontritkulás kezelésében
GB0711776D0 (en) * 2007-06-18 2007-07-25 Syngenta Participations Ag Substituted aromatic heterocyclic compounds as fungicides
EP2566856B1 (en) * 2010-05-05 2017-02-01 The Board of Trustees of the University of Illionis Compounds and methods of treating brain disorders
EP2751117A4 (en) * 2011-08-30 2015-06-24 Innocrin Pharmaceuticals Inc METALLOENZYMHEMMERVERBINDUNGEN
CN103214396B (zh) * 2013-04-10 2015-01-21 湖北工业大学 3-氰基苯甲酸的生产方法
CN103193658A (zh) * 2013-04-18 2013-07-10 苏州永健生物医药有限公司 一种(r)-2-对硝基苯乙胺基-1-苯乙醇及其盐的合成方法

Also Published As

Publication number Publication date
HU9503743D0 (en) 1996-02-28
BR9406925A (pt) 1996-07-30
FI960078A0 (fi) 1996-01-08
IL110158A (en) 1999-07-14
FI960078A (fi) 1996-01-08
CA2164960A1 (en) 1995-01-19
CN1047169C (zh) 1999-12-08
CN1126991A (zh) 1996-07-17
JPH08512314A (ja) 1996-12-24
US5712299A (en) 1998-01-27
NO960030D0 (no) 1996-01-04
IL110158A0 (en) 1994-10-07
SG48081A1 (en) 1998-04-17
AU691821B2 (en) 1998-05-28
AU7197994A (en) 1995-02-06
NO305953B1 (no) 1999-08-23
CZ4296A3 (en) 1996-06-12
EP0707574A1 (en) 1996-04-24
PL312428A1 (en) 1996-04-29
MX9405111A (es) 1995-01-31
NZ268691A (en) 1997-09-22
PL179015B1 (pl) 2000-07-31
ZA944647B (en) 1995-01-06
HUT74671A (en) 1997-01-28
NO960030L (no) 1996-01-04
WO1995001968A1 (en) 1995-01-19

Similar Documents

Publication Publication Date Title
KR101855471B1 (ko) 다환형 화합물 및 이의 사용 방법
FR2823209A1 (fr) Nouvelles thiohydantoines et leur utilisation en therapeutique
EA002763B1 (ru) Альфа-аминоамидные производные, полезные в качестве анальгетических агентов
SK160095A3 (en) Novel (1-phenyl-1-heterocyclyl)methanol and (1-phenyl-1-heterocyclyl)methylamine derivatives
CA2149691A1 (en) Medicament for therapeutic and prophylactic treatment of diseases caused by smooth muscle cell hyperplasia
JPH10512252A (ja) 1−(3,4−ジクロロベンジル)−2−メチルアミノインダンの鏡像異性体
JPWO2019065794A1 (ja) Pac1受容体拮抗薬を用いた鎮痛薬
RU2137763C1 (ru) Производные (1-фенил-1-гетероциклил)алкана, способ их получения, фармацевтический препарат, обладающий нейрозащитным действием при ишемии головного мозга, способ лечения гипоксических и асфиксических поражений мозга
EP0929550A1 (fr) DERIVES DE $i(N)-(BENZOTHIAZOL-2-YL)PIPERIDINE-1-ETHANAMINE, LEUR PREPARATION ET LEUR APPLICATION EN THERAPEUTIQUE
EP0306825B1 (en) N-(substituted alkylidene)-1,2,3,4,-tetrahydro-9-acridinamines, a process for their preparation and their use as medicaments
JP3094077B2 (ja) 5−(2−クロロ−1−ヒドロキシエチル)−4−メチルチアゾール含有の医薬製剤
RU2139863C1 (ru) Производные оксазолил- или тиазолилметанола, способы их получения (варианты), фармацевтический препарат и способ лечения нейро-дегенеративных нарушений
JP4378616B2 (ja) 2−ヘテロ環式−1,2−エタンジオールのカルバメート
CA2432959A1 (fr) Modulateurs de canaux sodiques derives de 2-piperidylimidazoles
JPH10503172A (ja) 新しい1,1−ビス(ヘテロアゾリル)アルカン誘導体および神経保護剤としてのその使用
FR2757512A1 (fr) Utilisation de benzoylalkyl-1-1,2,3,6-tetrahydropyridines
BE1009520A5 (fr) Acide (-)-(3r)-3-methyl-4- 4-[4-(4-pyridyl)-piperazin-1-yl] phenoxy butyrique.
KR20090100443A (ko) 심혈관 질환 치료용 1,3-디히드로이미다졸
JPH0352888A (ja) 新規化合物、その製法及びそれを含む医薬組成物
FR2707986A1 (fr) Nouveaux composés, leur procédé de préparation et leur utilisation en tant que médicaments.
JPH07500571A (ja) Pcpレセプター・リガンドおよびその用途
FR2734818A1 (fr) Acide (-)-(3r)-3-methyl-4-{4-[4-(4-pyridyl)piperazine-1-yl- phenoxy}-butyrique, procede pour sa preparation et composition pharmaceutique le contenant
CS228943B2 (cs) Způsob výroby substituovaných derivátů 1,4-dihydropyridinu
FR2729148A1 (fr) Nouveaux derives d'amine, leur procede de preparation et leur utilisation en tant que medicaments et notamment en tant qu'agents anti-arythmiques
FR2729149A1 (fr) Nouveaux derives de carboline, leur procede de preparation et leur utilisation en tant que medicaments et notamment en tant qu'agents anti-arythmiques